DX, N., M, P., NN, S., JM, C., Jr, B. T., RR, W., . . . DD, H. (2022). Donor source and post-transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency. British journal of haematology, 196(1), 169. https://doi.org/10.1111/bjh.17840
Chicago Style (17th ed.) CitationDX, Nichols-Vinueza, et al. "Donor Source and Post-transplantation Cyclophosphamide Influence Outcome in Allogeneic Stem Cell Transplantation for GATA2 Deficiency." British Journal of Haematology 196, no. 1 (2022): 169. https://doi.org/10.1111/bjh.17840.
MLA (9th ed.) CitationDX, Nichols-Vinueza, et al. "Donor Source and Post-transplantation Cyclophosphamide Influence Outcome in Allogeneic Stem Cell Transplantation for GATA2 Deficiency." British Journal of Haematology, vol. 196, no. 1, 2022, p. 169, https://doi.org/10.1111/bjh.17840.